ICON plc · Dublin Ireland ·(Irish: IJF)(NASDAQ (GS): ICLR)

By the time a new drug hits the market, it has passed through a series of clinical trials to demonstrate its safety and effectiveness; guiding drugs through that process is what ICON does best. The contract research organization provides drugmakers and medical device companies around the world with a broad range of services for their product candidates' clinical trials. ICON designs studies and recruits investigators; manages and analyzes trial data; writes reports and other documents; and assists with regulatory filings. Spanning the full development cycle, it also helps with preclinical drug development and post-approval safety monitoring. ICON has operations in more than 35 countries around the world. To read the full description, subscribe now.